Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
SPI-452
print preview
bookmark
share with colleague
General Information
Company
Sequoia Pharmaceuticals Inc.
Description
Cytochrome P450 3A4 (CYP3A4) inhibitor
Molecular Target
Cytochrome P450 3A4 (CYP3A4)
Mechanism of Action
Cytochrome P450 3A (CYP3A) inhibitor
Latest Stage of Development
Phase I
Indication
HIV / AIDS
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy